Loading
Latest filing published 08 Feb 2024 for Oryzon Genomics, S.A., €11k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ana Limon Carrera is a declared insider of Oryzon Genomics, S.A., with filings sourced from CNMV. Between 6 February 2023 and 6 February 2024, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 8 February 2024: a transaction of €11k, in Oryzon Genomics, S.A. Every figure here comes from the filings published by CNMV and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations